alendronate has been researched along with calcium phosphate, dibasic, dihydrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouler, JM; Bujoli, B; Despas, C; Fayon, F; Gauthier, O; Janvier, P; Khairoun, I; Massiot, D; Mellier, C; Montavon, G; Rouillon, T; Schnitzler, V; Walcarius, A | 1 |
| Chen, X; Gao, C; Gou, Z; Huang, R; Li, Z; Sun, X; Xia, W; Yang, G; Yang, X; Zhang, G | 1 |
2 other study(ies) available for alendronate and calcium phosphate, dibasic, dihydrate
| Article | Year |
|---|---|
Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.
Topics: Adsorption; Alendronate; Apatites; Bone Cements; Calcium Phosphates; Dielectric Spectroscopy; Diphosphonates; Hip Fractures; Imidazoles; Magnetic Resonance Spectroscopy; Osteoporotic Fractures; Time Factors; Zoledronic Acid | 2011 |
Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.
Topics: Alendronate; Biomimetic Materials; Bone and Bones; Bone Density Conservation Agents; Calcium Phosphates; Cetrimonium; Cetrimonium Compounds; Durapatite; Micelles; Models, Biological; Nanoparticles; Phase Transition; Surface-Active Agents; Time Factors | 2012 |